WestPark Capital Initiates Coverage On Veru with Buy Rating, Announces Price Target of $28

10/6/2026
Impact: 75
Healthcare

WestPark Capital analyst Ed Arce has initiated coverage on Veru (NASDAQ: VERU) with a Buy rating. The firm has set a price target of $28 for the stock.

AI summary, not financial advice

Share: